Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

The Lancet - Tập 396 - Trang 535-544 - 2020
Marina Pollán1,2, Beatriz Pérez-Gómez1,2, Roberto Pastor-Barriuso1,2, Jesús Oteo3,4, Miguel A Hernán5,6,7, Mayte Pérez-Olmeda3, Jose L Sanmartín8, Aurora Fernández-García2,9, Israel Cruz10, Nerea Fernández de Larrea1,2, Marta Molina11, Francisco Rodríguez-Cabrera10, Mariano Martín8, Paloma Merino-Amador9, Jose León Paniagua12, Juan F Muñoz-Montalvo8, Faustino Blanco11, Raquel Yotti13
1National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain
2Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain
3National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain
4Spanish Network for Research in Infectious Diseases (REIPI), Institute of Health Carlos III, Madrid, Spain
5Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
6Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA
7Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA
8Deputy Directorate of Information Technologies, Ministry of Health, Madrid, Spain
9Department of Clinical Microbiology, Hospital Clínico San Carlos, Madrid, Spain
10National School of Public Health, Institute of Health Carlos III, Madrid, Spain
11General Secretary of Health, Ministry of Health, Madrid, Spain
12General Secretariat, Institute of Health Carlos III, Madrid, Spain
13Directorate, Institute of Health Carlos III, Madrid, Spain

Tài liệu tham khảo

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 Sood, 2020, Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10–11, 2020, JAMA, 10.1001/jama.2020.8279 Valenti, 2020, SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak, medRxiv Snoeck, 2020, Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study, medRxiv Salje, 2020, Estimating the burden of SARS-CoV-2 in France, Science, 10.1126/science.abc3517 Stringhini, 2020, Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland, medRxiv Bryan, 2020, Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho, J Clin Microbiol, 10.1128/JCM.00941-20 Garcia-Basteiro, 2020, Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital, medRxiv Shakiba, 2020, Seroprevalence of COVID-19 virus infection in Guilan province, Iran, medRxiv Doi, 2020, Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: a cross-sectional study, medRxiv Erikstrup, 2020, Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors, medRxiv Wu, 2020, Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China, J Med Virol, 10.1002/jmv.25904 Temperton Bobrovitz, 2020, Lessons from a rapid systematic review of early SARS-CoV-2 serosurveys, medRxiv Li, 2020, Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis, J Med Virol Hoffman, 2020, Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2, Infect Ecol Epidemiol, 10 Chen, 2020, National Health and Nutrition Examination Survey, 2015–2018: sample design and estimation procedures, Vital Health Stat 2, 184, 1 Bryant, 2020, Serology for SARS-CoV-2: apprehensions, opportunities, and the path forward, Science Immunology, 5, 10.1126/sciimmunol.abc6347 Huang, 2020, A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease, medRxiv Bunyavanich, 2020, Nasal gene expression of angiotensin-converting enzyme 2 in children and adults, JAMA, 10.1001/jama.2020.8707 Folgueira, 2020, SARS-CoV-2 infection in health care workers in a large public hospital in Madrid, Spain, during March 2020, medRxiv Peak, 2020, Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study, Lancet Infect Dis, 10.1016/S1473-3099(20)30361-3 Metcalf, 2016, Use of serological surveys to generate key insights into the changing global landscape of infectious disease, Lancet, 388, 728, 10.1016/S0140-6736(16)30164-7 Byambasuren, 2020, Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis, medRxiv Wajnberg, 2020, Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region, medRxiv Zhao, 2020, Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Clin Infect Dis, 10.1093/cid/ciaa344 Tay, 2020, The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol, 10.1038/s41577-020-0311-8 Kim, 2020, Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis, Radiology, 10.1148/radiol.2020201343 Huang, 2020, Long period dynamics of viral load and antibodies for SARS-CoV-2 infection: an observational cohort study, medRxiv Theel, 2020, The role of antibody testing for SARS-CoV-2: is there one?, J Clin Microbiol, 10.1128/JCM.00797-20 To, 2020, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study, Lancet Infect Dis, 5, 565, 10.1016/S1473-3099(20)30196-1 Wang, 2020, A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays, J Clin Microbiol, 10.1128/JCM.00375-20 Abellan García